Table 1.
Study |
Country |
Design |
Cases |
Controls |
Outcome |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Genotypes |
|
Genotypes |
p_HWEc |
|||||||||
rs1800468 (−800 G/A) | N | GG | AG | AA | N | GG | AG | AA | ||||
Crobu et al, 2008
[22] |
Italy |
CC |
201 |
175 |
25 |
1 |
201 |
168 |
31 |
2 |
0.65 |
MI |
Sie et al, 2006
[21] |
Netherlands |
CO |
358 |
288 |
66 |
4 |
6098 |
5071 |
984 |
43 |
0.58 |
MI |
Syrris et al,1998
[14] |
England |
CC |
655 |
541 |
110 |
4 |
244 |
207 |
36 |
1 |
1 |
CAD |
Cambien et al,1996
[16] |
FR and NIE |
CC |
563 |
472 |
88 |
3 |
629 |
534 |
89 |
6 |
0.28 |
MI |
rs1800469 (−509 C/T) |
|
|
|
CC |
CT |
TT |
|
CC |
CT |
TT |
|
|
Sudomoina et al, 2010
[36]b |
Russia |
CC |
264 |
77 |
150 |
37 |
212 |
90 |
103 |
19 |
0.22 |
MI |
Drenos et al, 2009
[37] |
England |
CC |
240 |
120 |
100 |
20 |
2143 |
1090 |
885 |
168 |
0.56 |
CAD |
Crobu et al, 2008
[22] |
Italy |
CC |
201 |
67 |
87 |
47 |
201 |
80 |
92 |
29 |
0.76 |
MI |
Koch et al, 2006
[20] |
Germany |
CC |
3657 |
1581 |
1659 |
417 |
1211 |
564 |
508 |
139 |
0.13 |
MI |
Sie et al, 2006
[21] |
Netherlands |
CO |
355 |
171 |
156 |
28 |
6037 |
3043 |
2441 |
553 |
0.05 |
MI |
Syrris et al, 1998
[14] |
England |
CC |
655 |
301 |
284 |
70 |
244 |
124 |
97 |
23 |
0.54 |
CAD |
Cambien et al, 1996
[16] |
FR and NIE |
CC |
563 |
240 |
257 |
66 |
629 |
263 |
297 |
69 |
0.29 |
MI |
rs1982073 (868 T/C) |
|
|
|
TT |
TC |
CC |
|
TT |
TC |
CC |
|
|
Najar et al, 2011
[11] |
Iran |
CC |
900 |
301 |
424 |
175 |
900 |
395 |
403 |
102 |
1 |
MI |
Crobu et al, 2008
[22] |
Italy |
CC |
201 |
55 |
88 |
58 |
201 |
69 |
101 |
31 |
0.66 |
MI |
Koch et al, 2006
[20] |
Germany |
CC |
3657 |
1235 |
1802 |
620 |
1211 |
458 |
565 |
188 |
0.55 |
MI |
Sie et al, 2006
[21] |
Netherlands |
CO |
343 |
135 |
164 |
44 |
5844 |
2322 |
2698 |
824 |
0.37 |
MI |
Yokota et al, 2000
[23] |
Japan |
CC |
315 |
89 |
185 |
41 |
591 |
149 |
295 |
147 |
1 |
MI |
Syrris et al, 1998
[14] |
England |
CC |
655 |
242 |
306 |
107 |
244 |
102 |
109 |
33 |
0.68 |
CAD |
Cambien et al, 1996
[16] |
FR and NIE |
CC |
563 |
181 |
277 |
105 |
629 |
225 |
297 |
107 |
0.62 |
MI |
rs1800471 (913 G/C) |
|
|
|
GG |
GC |
CC |
|
GG |
GC |
CC |
|
|
Drenos et al, 2009
[37] |
England |
CC |
234 |
187 |
45 |
2 |
2071 |
1723 |
331 |
17 |
0.78 |
CAD |
Koch et al, 2006
[20] |
Germany |
CC |
3657 |
3149 |
486 |
22 |
1211 |
1063 |
141 |
7 |
0.33 |
MI |
Sie et al, 2006
[21] |
Netherlands |
CO |
343 |
297 |
45 |
1 |
5844 |
4992 |
823 |
29 |
0.51 |
MI |
Syrris et al, 1998
[14] |
England |
CC |
655 |
558 |
95 |
2 |
244 |
214 |
30 |
0 |
0.61 |
CAD |
Cambien et al, 1996
[16] |
FR and NIE |
CC |
563 |
464 |
92 |
7 |
629 |
546 |
81 |
2 |
1 |
MI |
rs1800472 (11929 C/T) |
|
|
|
CC |
CT |
TT |
|
CC |
CT |
TT |
|
|
Drenos et al, 2009
[37] |
England |
CC |
241 |
234 |
7 |
0 |
2145 |
2052 |
89 |
4 |
0.02 |
CAD |
Koch et al, 2006
[20] |
Germany |
CC |
3657 |
3421 |
231 |
5 |
1211 |
1138 |
72 |
1 |
1 |
MI |
Syrris et al, 1998
[14] |
England |
CC |
655 |
622 |
33 |
0 |
244 |
237 |
7 |
0 |
1 |
CAD |
Cambien et al, 1996 [16] | FR and NIE | CC | 590 | 563 | 27 | 0 | 629 | 585 | 42 | 2 | 0.20 | MI |
FR and NIE, France and Northern Ireland; CC, case–control; CO, cohort; MI, myocardial infarction; CAD, coronary artery disease.
a, For rs1800468, rs1982073 and rs1800471, 10090 additional subjects were included for the co-dominant model analysis from the PROCARDIS study [25]; for rs1800469, additional 10090 and 80016 subjects were included for the co-dominant model analysis, respectively from the PROCARDIS study [25] and the CARDIoGRAM study [24] (Additional file 2).
b, Additional unpublished data have been included.
c, The p values for Hardy-Weinberg equilibrium were derived from Fisher’s exact test.